Therapeutic Potential of Aspirin Repurposing in Colon Cancer
Claudia Iftode, Stela Iurciuc, Iasmina Marcovici, Ioana Macașoi, Dorina Coricovac, Cristina Dehelean, Sorin Ursoniu, Andreea Rusu, Simona Ardelean
Abstract
Repurposing existing drugs for new therapeutic applications offers significant advantages over conventional drug development. Since these drugs have already passed safety evaluations, their failure rate is significantly reduced. In addition, leveraging pre-existing clinical data and established manufacturing methods accelerates the development process and reduces costs. While bringing a new drug to market typically requires 10-17 years and $2-3 billion, repurposed drugs can become available in 3
Topics & Concepts
RepurposingAspirinColorectal cancerMedicineCancerOncologyInternal medicineBiologyEcologyColorectal Cancer Treatments and StudiesLung Cancer Treatments and MutationsGastric Cancer Management and Outcomes